Correction: eCF309: a potent, selective and cell-permeable mTOR inhibitor
Abstract
Correction for ‘eCF309: a potent, selective and cell-permeable mTOR inhibitor’ by Craig Fraser et al., MedChemComm, 2016, DOI: 10.1039/c5md00493d.
* Corresponding authors
a
Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Crewe Road South, Edinburgh EH4 2XR, UK
E-mail:
Asier.Unciti-Broceta@igmm.ed.ac.uk
Correction for ‘eCF309: a potent, selective and cell-permeable mTOR inhibitor’ by Craig Fraser et al., MedChemComm, 2016, DOI: 10.1039/c5md00493d.
C. Fraser, N. O. Carragher and A. Unciti-Broceta, Med. Chem. Commun., 2016, 7, 562 DOI: 10.1039/C6MD90009G
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content